Advertisement

Measuring Health Related Quality of Life

An international perspective
  • Monika Bullinger
Part of the Advances in Experimental Medicine and Biology book series (AEMB, volume 528)

Keywords

Life Assessment Recombinant Human Erythropoietin Life Instrument Cardiac Arrhythmia Suppression Trial Symptomatic Human Immunodeficiency Virus 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. 1.
    Najman, J.M., and Levine, S., 1981, Evaluating the impact of medical care and technology on quality of life. A review and critique. Soc. Sci. Med. 15F: 107–115.PubMedGoogle Scholar
  2. 2.
    Patrick, D.L., and Erickson, P., 1992, Health status and health policy. Oxford University Press, New York.Google Scholar
  3. 3.
    Bullinger, M., 1997, Health-related quality of life and subjective health. Psychother. Psychosom. Med. Psychol. 47: 76–91.PubMedGoogle Scholar
  4. 4.
    Spilker, B., 1996, Quality of life assessment in clinical trails. Raven Press, New York.Google Scholar
  5. 5.
    Cambell, I., 1981, The quality of American life. Russel-Sage, New York.Google Scholar
  6. 6.
    Glatzer, W., and Zapf, W., 1984, Lebensqualität in der Bundesrepublik Deutschland. Campus: Frankfurt.Google Scholar
  7. 7.
    Guyatt, G.H., Feeny, D.H., and Patrick, D.L., 1993, Measuring health-related quality of life. Ann. Intern. Med. 118: 622–629.PubMedGoogle Scholar
  8. 8.
    Lydick, E.G., and Epstein, R.S., 1996, Clinical significance of quality of life data. In Quality of life and pharmaeconomics in clinical trials (B. Spilker, ed.), Lippincott-Raven, Philadelphia, pp. 461–466.Google Scholar
  9. 9.
    Schipper, H., Clinch, J.J., and Olweny, Ch.L.M., 1996, Quality of life studies. Definition and conceptual issues, In Quality of life and pharmaeconomics in clinical trials (B. Spilker, ed.), Lippincott-Raven, Philadelphia, pp. 11–24.Google Scholar
  10. 10.
    Bullinger, M., 1991, Quality of life — Definition, conceptualization and implications. A methodologists view. Theor. Surgery 6: 143–148.Google Scholar
  11. 11.
    Ludwig, M., 1991, Implizite Therapiebildung in der Lebensqualität. In Lebensqualität bei kardiovaskulären Erkrankungen (M. Bullinger, M. Ludwig, und N. von Steinbüchel, Hrsg.), Hogrefe, Stuttgart, pp. 3–12.Google Scholar
  12. 12.
    Bowling, A., 1991, Measuring health. A review of quality of life measurement scales. Milton Keynes, Open University Press, Philadelphia.Google Scholar
  13. 13.
    Bullinger, M., Power, M.J., Aaronson, N.K., et al., 1996, Creating and evaluating cross-cultural instruments. In Quality of life and pharmaeconomics in clinical trials (B. Spilker, ed.), Lippincott-Raven, Philadelphia, pp. 659–668.Google Scholar
  14. 14.
    Aaronson, N.K., Cull, A.M., Stein K., et al., 1996, The European organization for research and treatment of cancer (EORTC). Modular approach to quality of life assessment in oncology. An update. In Quality of life and pharmaeconomics in clinical trials (B. Spilker, ed.), Lippincott-Raven, Philadelphia, pp. 179–190.Google Scholar
  15. 15.
    Hunt, S.M., McEwen, J., McKenna, S.P., et al. 1981, The Nottingham health profile. Subjective health status and medical consultations. Soc. Sci. Med. 15A: 221–229.Google Scholar
  16. 16.
    Ware, J.E., 1996, The SF-36 health survey.. In Quality of life and pharmaeconomics in clinical trials (B. Spilker, ed.), Lippincott-Raven, Philadelphia, pp. 337–346.Google Scholar
  17. 17.
    Orley, J. and the WHOQOL-Group, 1994, The development of the WHO quality of life assessment instruments (The WHOQOL). In Quality of life assessment, international perspectives (J. Orley, and W. Kuyken, eds.), Springer, Berlin, pp.41–57.Google Scholar
  18. 18.
    Ware, J.E., 1987, Standards for validating health measures. Definition and content. J. Chronic Dis. 40: 503–512.Google Scholar
  19. 19.
    Cella, D.F., and Bonomi, A.E., 1996, The functional assessment of cancer therapy (FACT) and functional assessment of HIV infection (FAHI) quality of life measurement system. In Quality of life and pharmaeconomics in clinical trials (B. Spilker, ed.), Lippincott-Raven, Philadelphia, pp. 203–214.Google Scholar
  20. 20.
    Bullinger, M., 1997, The challenge of cross-cultural quality of life assessment. Psychol. Health 12: 815–825.Google Scholar
  21. 21.
    Kornblith, A.B., Hollis, D.R., Zuckerman, E., et al., 1993, Effect of megestrol acetate on quality of life in a dose-response trial in women with advanced breast cancer. The cancer and leukemia group B. J. Clin. Oncol. 11: 2081–2089.PubMedGoogle Scholar
  22. 22.
    Bulpitt, C.J., Fletcher, A.E., 1994, Quality of life and the heart. Evaluation of therapeutic alternatives. Br. J. Clin. Practice 73 (suppl.): 18–22.Google Scholar
  23. 23.
    Croog, S.H., Levine, S., and Testa, M.A., 1986, The effect of antihypertensive therapy on the quality of life. N. Engl. J. Med. 314: 1657–1664.PubMedGoogle Scholar
  24. 24.
    Wiklund, I., Gorkin, L., Pawitan, Y., et al., 1992, Methods for assessing quality of life in the cardiac arrhythmia suppression trial (CAST). Quality Life Res. 1: 187–201.CrossRefGoogle Scholar
  25. 25.
    Ekeberg, O., Klemsdal, T.O., and Kjeldsen, S.E., 1994, Quality of life on enalapril after acute myocardial infarction. Eur. Heart J. 15: 1135–1139.PubMedGoogle Scholar
  26. 26.
    Naber, D., 1998, Subjective experiences of schizophrenic patients treated with antipsychotic medication. Int. J. Clin. Psychopharmacol. 13 (suppl. 1): 41–45.Google Scholar
  27. 27.
    Wagner, A.K., and Vickrey, B.G., 1995, The routine use of health-related quality of life measures in the care of patients with epilepsy. Rationale and research agenda. Quality Life Res., 4: 169–177.Google Scholar
  28. 28.
    Dodrill, C.B., Arnett, J.L., Sommerville, K.W., et al., 1995,. Effects of differing dosages of vigabatrin (Sabril) on cognitive abilities and qualities of life in epilepsy. Epilepsia 36: 164–173.CrossRefPubMedGoogle Scholar
  29. 29.
    McMahon, L.P., and Dawborn, J.K., 1992, Subjective quality of life assessment in hemodialysis patients at different levels of hemoglobin following use of recombinant human erythropoietin. Am. J. Nephrol. 12: 162–169.PubMedGoogle Scholar
  30. 30.
    Solomon, G.D., Skobieranda, F.G., and Gragg, L.A., 1993, Quality of life and wellbeing of headache patients. Measurement by the medical outcomes study instrument. Headache 33:351–358.CrossRefPubMedGoogle Scholar
  31. 31.
    Cunningham, W.E., Hays, R.D., Williams, K.W., et al., 1995, Access to medical care and health-related quality of life for low-income persons with symptomatic human immunodeficiency virus. Med. Care 33: 739–754.PubMedGoogle Scholar
  32. 32.
    Revicki, D.A., Brown, R.E., Henry, D.H., et al., 1994, Recombinant human erythropoietin and health-related quality of life of AIDS patients with anemia. AIDS 7: 474–484.Google Scholar
  33. 33.
    Troidl, H., Wood-Dauphinee, S., and Williams, I., 1980, Endpoints in surgical trials. Thieme, New York.Google Scholar
  34. 34.
    Joyce, C.R., 1994, Health status or quality of life. Which matters to the patient? J. Cardiovasc. Pharmacol. 23: S26–S33.PubMedGoogle Scholar

Copyright information

© Kluwer Academic Publishers 2004

Authors and Affiliations

  • Monika Bullinger
    • 1
  1. 1.Department of Medical PsychologyUniversity of HamburgHamburgGermany

Personalised recommendations